MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign with Hundreds of Events to Advance Research and Care for the Neuromuscular Disease Community
August 26, 2024 08:58 ET
|
Muscular Dystrophy Association
New York, Aug. 26, 2024 (GLOBE NEWSWIRE) -- September marks the kick-off of the Muscular Dystrophy Association (MDA) ‘National Muscular Dystrophy Awareness Month’ to raise awareness and critical...
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
August 19, 2024 09:15 ET
|
Muscular Dystrophy Association
New York, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) in partnership with the International Association of Fire Fighters (IAFF) kick off more than 420 Fill the Boot...
Registration Now Open for the 2025 MDA Clinical & Scientific Conference Featuring the Latest Innovations in Neuromuscular Disease Research and Care with Global Leaders, March 16-19 in Dallas, TX
July 30, 2024 11:53 ET
|
Muscular Dystrophy Association
New York, July 30, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA), convener of the largest global gathering of the neuromuscular disease community, announced today that...
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
May 28, 2024 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
MDA's Pinup & Roundup Campaigns Kick Off Across the Nation to Support Summer Camp for Kids and Young Adults Living with Neuromuscular Diseases
May 20, 2024 09:15 ET
|
Muscular Dystrophy Association
New York, May 20, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the launch of its annual MDA Summer Camp retail fundraising campaign, in collaboration with over...
Muscular Dystrophy Association Celebrates Historic Advancements in Accessible Air Travel as Congress Passes FAA Reauthorization
May 15, 2024 14:57 ET
|
Muscular Dystrophy Association
Washington, D.C., May 15, 2024 (GLOBE NEWSWIRE) -- Today, the Muscular Dystrophy Association (MDA) celebrates a landmark achievement in accessible air travel as Congress grants final passage to the...
Muscular Dystrophy Association Launches ‘Access The Vote’ Campaign to Amplify Rights of Accessible Voting
April 23, 2024 08:49 ET
|
Muscular Dystrophy Association
Washington, D.C., April 23, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce the launch of its latest MDA Advocacy initiative, the ‘Access The Vote’ Campaign,...
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide for Muscular Dystrophy Association
April 10, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, April 10, 2024 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) celebrates 70 years of partnership with the International Association of Fire Fighters (IAFF) kicking off more...
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
March 28, 2024 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
March 27, 2024 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing,...